Literature DB >> 21642598

Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow.

Thomas Matthes1, Isabelle Dunand-Sauthier, Marie-Laure Santiago-Raber, Karl-Heinz Krause, Olivier Donze, Jakob Passweg, Tomas McKee, Bertrand Huard.   

Abstract

The bone marrow (BM) is an organ extremely efficient in mediating long-term survival of plasma cells (PCs), ensuring an immune humoral memory. This implies that the BM must provide continuously key PC survival factors. Our results show that the BM is an organ constitutively rich in a proliferation-inducing ligand (APRIL), a member of the tumor necrosis factor superfamily implicated in PC survival. APRIL production is induced during hematopoiesis in myeloid cells by non-lineage-committing factors such as stem cell factor, thrombopoietin, IL-3, and FMS-like tyrosine kinase 3 ligand. Notably, APRIL production, both in the human and mouse systems, peaks in myeloid precursor cells, before dropping in fully mature granulocytes. Myeloid cells secrete APRIL that circulates freely in BM plasma to act on PCs, usually at distance from APRIL production sites. Selective APRIL in vivo antagonism and in vitro coculture experiments further demonstrated that myeloid precursor cells mediates PC survival in an APRIL-dependent manner Thus, APRIL production by myeloid precursor cells shows that the 2 main BM functions, hematopoiesis and long-term PC survival, are linked. Such constitutive and high APRIL production may explain why BM mediates long-term PC survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642598     DOI: 10.1182/blood-2011-01-332940

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.

Authors:  Abby Jones Weldon; Ioana Moldovan; Marven G Cabling; Elvin A Hernandez; Sheri Hsu; Jennifer Gonzalez; Andrea Parra; Abigail Benitez; Nasim Daoud; Keith Colburn; Kimberly J Payne
Journal:  J Rheumatol       Date:  2015-03-01       Impact factor: 4.666

Review 2.  [Stromal cells as coordinators of adaptive immune response and immunological memory].

Authors:  A E Hauser
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

3.  Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow.

Authors:  T Matthes; B Manfroi; A Zeller; I Dunand-Sauthier; B Bogen; B Huard
Journal:  Leukemia       Date:  2015-06-19       Impact factor: 11.528

Review 4.  Activation of B cells by non-canonical helper signals.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  EMBO Rep       Date:  2012-08-07       Impact factor: 8.807

5.  Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.

Authors:  Masahiro Muto; Benoit Manfroi; Hitoshi Suzuki; Kensuke Joh; Masaaki Nagai; Sachiko Wakai; Christian Righini; Masayuki Maiguma; Shozo Izui; Yasuhiko Tomino; Bertrand Huard; Yusuke Suzuki
Journal:  J Am Soc Nephrol       Date:  2016-12-05       Impact factor: 10.121

6.  Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.

Authors:  Gang An; Chirag Acharya; Xiaoyan Feng; Kenneth Wen; Mike Zhong; Li Zhang; Nikhil C Munshi; Lugui Qiu; Yu-Tzu Tai; Kenneth C Anderson
Journal:  Blood       Date:  2016-07-14       Impact factor: 22.113

7.  B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma.

Authors:  Yu-Tzu Tai; Kenneth C Anderson
Journal:  Expert Opin Biol Ther       Date:  2019-07-11       Impact factor: 4.388

8.  Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Authors:  T Matthes; T McKee; I Dunand-Sauthier; B Manfroi; S Park; J Passweg; B Huard
Journal:  Leukemia       Date:  2015-03-10       Impact factor: 11.528

9.  APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.

Authors:  Yu-Tzu Tai; Chirag Acharya; Gang An; Michele Moschetta; Mike Y Zhong; Xiaoyan Feng; Michele Cea; Antonia Cagnetta; Kenneth Wen; Hans van Eenennaam; Andrea van Elsas; Lugui Qiu; Paul Richardson; Nikhil Munshi; Kenneth C Anderson
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

Review 10.  Eosinophils in Helminth Infection: Defenders and Dupes.

Authors:  Lu Huang; Judith A Appleton
Journal:  Trends Parasitol       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.